The Eyes Have It

All of the projects have come to completion and I’m hoping to begin publishing on a more regular schedule again.

The biggest obstacle to keeping TEHI going (in case you were wondering) was being on the Merck team that went before an FDA advisory committee yesterday. We were down in an unexpectedly snowy Sliver Springs, Maryland to present data from the LIFE study in support of a new indication for COZAAR (losartan). Luckily for everyone involved, I wasn’t one of the speakers.

It’s kind of interesting to see the reporters in the meeting room leaning over laptops, writing in real time as deliberations progress, stories that I know will be filed and online long before I’ll be home. Thing have changed a bit since the semester I spent as a journalism major 20 years ago.